Cardiovascular Disease Management - 4th Annual Symposium

What Role do the New PCSK9 Inhibitors Have in Lipid Lowering Treatment?

By Cardiovascular Disease Management - 4th Annual Symposium
By Cardiovascular Disease Management - 4th Annual Symposium
0 views
April 10, 2017
Comments 0
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Recommended

AUTOPLAY
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
19:48
ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano
39:44
The Texas Heart Institute

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Feat. S. Virani
33:43
Jefferson Health

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Feat. A. Cohen
25:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

How to Reduce Cholesterol and Triglycerides to Prevent CV Events

Feat. P. Taub
27:12
Norman Lepor

Update on Lipoprotein A: The Horrible Cholesterol

31:50
Nadir Ali

Do Statins Prevent or Cause Heart Disease? Should LDL Be Called &quo…

20:44
MUSC Cardiology

Big Questions About Lipoprotein “Little” (a)

Feat. A. Arana Waring
06:48
Complex Coronary Cases

LIVE Round Table: Panel Discussion on Lipid Management

Feat. R. Mehran
42:28
Houston Methodist DeBakey Heart and Vascular Center

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

Feat. C. Ballantyne
33:21
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

Newer Recommendations, Therapies, and Evidence for Improving Lipid C…

Feat. N. Wong
26:32
ACC 2024 Insights

ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Don…

Feat. S. Mora